Dolatrox^® is the composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate, for which the characteristics of innovation and uniqueness have been recognized. For an action aimed at maintaining the normal cartilage structure.

"Obtaining the fourth patent, in a country like the United States, a worldwide reference in scientific research, is a huge source of pride for us" - comments the president, Rita Paola Petrelli.

Research and innovation, with KOLINPHARMA^®, always alongside people's well-being.